HCW Biologics (HCWB) Cash & Current Investments (2020 - 2025)
Historic Cash & Current Investments for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $1.1 million.
- HCW Biologics' Cash & Current Investments rose 969.09% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 969.09%. This contributed to the annual value of $4.7 million for FY2024, which is 3002.62% up from last year.
- According to the latest figures from Q3 2025, HCW Biologics' Cash & Current Investments is $1.1 million, which was up 969.09% from $2.4 million recorded in Q2 2025.
- Over the past 5 years, HCW Biologics' Cash & Current Investments peaked at $73.8 million during Q3 2021, and registered a low of $1.0 million during Q3 2024.
- Its 5-year average for Cash & Current Investments is $24.1 million, with a median of $8.2 million in 2021.
- As far as peak fluctuations go, HCW Biologics' Cash & Current Investments soared by 103907.88% in 2022, and later crashed by 9544.43% in 2024.
- Over the past 5 years, HCW Biologics' Cash & Current Investments (Quarter) stood at $69.4 million in 2021, then plummeted by 43.9% to $38.9 million in 2022, then tumbled by 90.77% to $3.6 million in 2023, then surged by 30.03% to $4.7 million in 2024, then plummeted by 76.53% to $1.1 million in 2025.
- Its Cash & Current Investments was $1.1 million in Q3 2025, compared to $2.4 million in Q2 2025 and $1.1 million in Q1 2025.